Alvotech (ALVO) Current Leases (2020 - 2026)
Alvotech's (ALVO) quarterly Current Leases came in at $11.8 million in Q2 2026, down 13.04% on a YoY basis from $13.6 million in Q2 2025, and down 9.96% quarter-over-quarter from $13.1 million in Q1 2026.
Analysis
Alvotech (ALVO) Current Leases (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Current Leases for 7 consecutive years, with $11.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Current Leases fell 13.04% year-over-year to $11.8 million; the trailing twelve-month figure through Jun 2026 stood at $11.8 million (down 13.04% YoY), and the FY2025 full-year result was $12.1 million, up 26.94% from the prior year.
- Current Leases fell to $11.8 million in Q2 2026 per ALVO's latest filing, from $13.1 million in the prior quarter.
- Across five years, Current Leases topped out at $13.6 million in Q2 2025 and bottomed at $5.2 million in Q4 2022.
- Historically, Current Leases has averaged $10.6 million across 5 years, with a median of $11.1 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Current Leases retreated 29.23% in 2022, then soared 87.55% in 2023.
- Over 5 years, Current Leases stood at $5.2 million in 2022, then jumped by 87.55% to $9.7 million in 2023, then dropped by 1.73% to $9.5 million in 2024, then grew by 26.94% to $12.1 million in 2025, then decreased by 2.14% to $11.8 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $11.8 million, $13.1 million, and $12.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.62 Bn | 38.96 Bn | 2.15 Bn | - |
| 2 | Viatris | 18.96 Bn | 18.08 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.79 Bn | 9.61 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.49 Bn | 5.36 Bn | 334.51 Mn | 9.04 Mn |
| 5 | Bausch Health Companies | 2.29 Bn | 453.25 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn | 11.82 Mn |
| 7 | Ani Pharmaceuticals | 1.50 Bn | 1.14 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.01 Bn | 719.36 Mn | 93.47 Mn | 8.80 Mn |
| 9 | Fennec Pharmaceuticals | 401.07 Mn | 359.82 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 173.61 Mn | 173.61 Mn | - | 900,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.82 Mn |
| Mar 31, 2026 | 13.13 Mn |
| Dec 31, 2025 | 12.08 Mn |
| Sep 30, 2025 | 13.30 Mn |
| Jun 30, 2025 | 13.59 Mn |
| Mar 31, 2025 | 11.07 Mn |
| Dec 31, 2024 | 9.52 Mn |
| Sep 30, 2024 | 11.58 Mn |
| Jun 30, 2024 | 10.64 Mn |
| Mar 31, 2024 | 11.16 Mn |
| Dec 31, 2023 | 9.68 Mn |
| Jun 30, 2023 | 7.98 Mn |
| Dec 31, 2022 | 5.16 Mn |
| Jun 30, 2022 | 7.28 Mn |
| Dec 31, 2021 | 7.30 Mn |
| Dec 31, 2020 | 5.47 Mn |